Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 1 hour 54 min ago

'Fingerprint database' could help pinpoint environmental cancer causes

18/04/2019
Until now, scientists have had only a limited number of tools for working out the cause of an individual’s tumour.

NICE final guidance published for Cimzia

18/04/2019
For adults who have failed to respond to, or are unsuitable for, other systemic therapies.

Public ‘unaware’ they have a choice of hospitals for NHS treatment

18/04/2019
The legal right to choice has been in place for over a decade, but just 48% of the public are currently aware of it.

PureTech Health, Boehringer Ingelheim enter $26M immuno-oncology deal

18/04/2019
PureTech Health will receive up to $26 million under the transaction.

Tickets available for the 20th International Clinical Researcher of the Year gala dinner & awards ceremony

17/04/2019
Tickets are available for those wanting to be a part of one of the most important dates in the clinical research calendar – an evening of celebration and recognition for the very best clinical researchers from across the globe

New data reinforce effectiveness of Novartis’ Zolgensma for SMA

17/04/2019
The Phase III STR1VE data showed that 21 patients were alive and event-free as of September 27 last year.

LifeArc licenses discovery programme to Daiichi Sankyo

17/04/2019
The deal successfully concludes a research collaboration between LifeArc, Oxford University’s Nuffield Department of Clinical Neurosciences and Daiichi Sankyo.

Trial results show promise for chemo-free future treatment

17/04/2019
95% of those treated in the study were found to have a complete remission rate.

‘Landmark’ day for Akcea as NICE recommends Tegsedi in rare inherited hATTR

17/04/2019
The decision will allow patients in England with the rare, inherited, severely debilitating and fatal disease to access the treatment on the NHS.

Novartis’ wet AMD drug gets FDA filing

17/04/2019
The decision is primarily based on Phase III data from the HAWK and HARRIER trials.

Less than 3 weeks left until the Clinical Researcher of the Year – The Americas gala dinner & awards ceremony

16/04/2019
The PharmaTimes Clinical Researcher of the Year – The Americas gala dinner & awards ceremony will be taking place at the Sheraton Hotel in Boston on 4th May.

Genomics England completes first phase of liquid biopsy study

16/04/2019
The results will enable researchers to perform an objective technology evaluation of the various market offerings in liquid biopsy in the second stage.

AI could identify existing drugs to help treat eye disease

16/04/2019
The research identified seven existing drugs - either already in development or being used to treat other conditions.

Enesi and BARDA to co-develop flu vaccines

16/04/2019
The public-private partnership aims to provide a cost-effective technological innovation.

New digital tool helps relieve pressure on NHS

16/04/2019
Over 6,250 care homes have already signed up to the system, which is accessible on any device.

‘Half a million’ GP hours freed for patients

16/04/2019
The three-year extension is part of a £30 million investment in a national programme for General Practice Development.

FDA approves first targeted therapy for metastatic bladder cancer

16/04/2019
The decision was based on a clinical trial showing an objective response rate of 32.2%.

BMS, Celgene shareholders back mega merger

16/04/2019
The decision was won by a majority of more than 75%.

AZ finds lack of lung cancer info available for patients

15/04/2019
Available information is often outdated and sometimes inaccurate.

Data show J&J’s Invokana may slow or prevent CKD in diabetes patients

15/04/2019
The data provides the first significant update in nearly 20 years regarding slowing the progression of CKD in patients with type II diabetes.

Pages

X